Product Pathways - Tyrosine Kinase / Adaptors
EGF Receptor (C74B9) Rabbit mAb #2646
|2646S||100 µl (10 western blots)||---||In Stock||---|
|2646||carrier free and custom formulation / quantity||email request|
Already purchased this product? Write a Review.
|W||1:1000||Human, Mouse, Rat, Monkey||Endogenous||175||Rabbit IgG|
Species cross-reactivity is determined by western blot.
Applications Key: W=Western Blotting, IP=Immunoprecipitation
Specificity / Sensitivity
EGF Receptor (C74B9) Rabbit mAb detects endogenous levels of total EGF receptor protein. The antibody may cross-react with other proteins of the ErbB family.
Source / Purification
Monoclonal antibody is produced by immunizing animals with a recombinant fusion protein containing the cytoplamic domain of human EGF receptor.
The epidermal growth factor (EGF) receptor is a transmembrane tyrosine kinase that belongs to the HER/ErbB protein family. Ligand binding results in receptor dimerization, autophosphorylation, activation of downstream signaling, internalization, and lysosomal degradation (1,2). Phosphorylation of EGF receptor (EGFR) at Tyr845 in the kinase domain is implicated in stabilizing the activation loop, maintaining the active state enzyme, and providing a binding surface for substrate proteins (3,4). c-Src is involved in phosphorylation of EGFR at Tyr845 (5). The SH2 domain of PLCγ binds at phospho-Tyr992, resulting in activation of PLCγ-mediated downstream signaling (6). Phosphorylation of EGFR at Tyr1045 creates a major docking site for the adaptor protein c-Cbl, leading to receptor ubiquitination and degradation following EGFR activation (7,8). The GRB2 adaptor protein binds activated EGFR at phospho-Tyr1068 (9). A pair of phosphorylated EGFR residues (Tyr1148 and Tyr1173) provide a docking site for the Shc scaffold protein, with both sites involved in MAP kinase signaling activation (2). Phosphorylation of EGFR at specific serine and threonine residues attenuates EGFR kinase activity. EGFR carboxy-terminal residues Ser1046 and Ser1047 are phosphorylated by CaM kinase II; mutation of either of these serines results in upregulated EGFR tyrosine autophosphorylation (10).
- Hackel, P.O. et al. (1999) Curr Opin Cell Biol 11, 184-9.
- Zwick, E. et al. (1999) Trends Pharmacol Sci 20, 408-12.
- Cooper, J.A. and Howell, B. (1993) Cell 73, 1051-4.
- Hubbard, S.R. et al. (1994) Nature 372, 746-54.
- Biscardi, J.S. et al. (1999) J Biol Chem 274, 8335-43.
- Emlet, D.R. et al. (1997) J Biol Chem 272, 4079-86.
- Levkowitz, G. et al. (1999) Mol Cell 4, 1029-40.
- Ettenberg, S.A. et al. (1999) Oncogene 18, 1855-66.
- Rojas, M. et al. (1996) J Biol Chem 271, 27456-61.
- Feinmesser, R.L. et al. (1999) J Biol Chem 274, 16168-73.
Have you published research involving the use of our products? If so we'd love to hear about it. Please let us know!
- 9922 Phospho-EGF Receptor Antibody Sampler Kit
- 3777 Phospho-EGF Receptor (Tyr1068) (D7A5) XP® Rabbit mAb
- 4267 EGF Receptor (D38B1) XP® Rabbit mAb
- 2239 EGF Receptor (1F4) Mouse mAb
- 2641 Phospho-EGF Receptor (Tyr998) (C24A5) Rabbit mAb
- 4405 EGF Receptor (15F8) Rabbit mAb
- 4407 Phospho-EGF Receptor (Tyr1173) (53A5) Rabbit mAb
- 2236 Phospho-EGF Receptor (Tyr1068) (1H12) Mouse mAb
- 2256 EGF Receptor (EGFR1) Mouse mAb (IP Specific)
- 2220 Phospho-EGF Receptor (Tyr1086) Antibody
- 2231 Phospho-EGF Receptor (Tyr845) Antibody
- 2232 EGF Receptor Antibody
- 2234 Phospho-EGF Receptor (Tyr1068) Antibody
- 2235 Phospho-EGF Receptor (Tyr992) Antibody
- 2237 Phospho-EGF Receptor (Tyr1045) Antibody
- 2238 Phospho-EGF Receptor (Ser1046/1047) Antibody
- 2963 EGF Receptor (T43) Antibody
- 3056 Phospho-EGF Receptor (Thr669) Antibody
- 3265 EGF Receptor (V279) Antibody
- 4404 Phospho-EGF Receptor (Tyr1148) Antibody
- 7071 Phototope®-HRP Western Blot Detection System, Anti-rabbit IgG, HRP-linked Antibody
- 7074 Anti-rabbit IgG, HRP-linked Antibody
- 7720 Prestained Protein Marker, Broad Range (Premixed Format)
- 7727 Biotinylated Protein Ladder Detection Pack
- 7003 20X LumiGLO® Reagent and 20X Peroxide
For Research Use Only. Not For Use In Diagnostic Procedures.
Cell Signaling Technology® is a trademark of Cell Signaling Technology, Inc.
This antibody is developed, validated, and produced by CST using in part technology under license (granting certain rights including those under U.S. Patent No. 5,675,063) from Epitomics, Inc.